Fennec Net Income vs Sale Purchase Of Stock Analysis
FENC Stock | USD 6.15 0.01 0.16% |
Fennec Pharmaceuticals financial indicator trend analysis is much more than just examining Fennec Pharmaceuticals latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Fennec Pharmaceuticals is a good investment. Please check the relationship between Fennec Pharmaceuticals Net Income and its Sale Purchase Of Stock accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.
Net Income vs Sale Purchase Of Stock
Net Income vs Sale Purchase Of Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Fennec Pharmaceuticals Net Income account and Sale Purchase Of Stock. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Fennec Pharmaceuticals' Net Income and Sale Purchase Of Stock is -0.13. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Sale Purchase Of Stock in the same time period over historical financial statements of Fennec Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Fennec Pharmaceuticals' Net Income and Sale Purchase Of Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Fennec Pharmaceuticals are associated (or correlated) with its Sale Purchase Of Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Sale Purchase Of Stock has no effect on the direction of Net Income i.e., Fennec Pharmaceuticals' Net Income and Sale Purchase Of Stock go up and down completely randomly.
Correlation Coefficient | -0.13 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Fennec Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Fennec Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Sale Purchase Of Stock
Most indicators from Fennec Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Fennec Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.At present, Fennec Pharmaceuticals' Enterprise Value is projected to increase significantly based on the last few years of reporting.
Fennec Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Fennec Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Fennec Pharmaceuticals fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 14.1M | 31.4M | 22.4M | 26.9M | 26.9M | 16.1M | |
Other Current Liab | 659K | 776K | 877K | 2.2M | 3.8M | 2.1M | |
Total Current Liabilities | 2.3M | 2.3M | 1.7M | 4.6M | 7.6M | 7.9M | |
Total Stockholder Equity | 11.9M | 29.1M | 15.8M | (2.6M) | (11.6M) | (11.0M) | |
Net Tangible Assets | 11.9M | 29.1M | 15.8M | (2.6M) | (3.0M) | (2.8M) | |
Net Debt | (13.7M) | (30.3M) | (16.1M) | 1.1M | 17.7M | 18.6M | |
Retained Earnings | (144.0M) | (162.1M) | (179.5M) | (203.2M) | (219.2M) | (208.3M) | |
Accounts Payable | 1.6M | 1.6M | 777K | 2.4M | 3.8M | 4.0M | |
Cash | 13.7M | 30.3M | 21.1M | 23.8M | 13.3M | 11.0M | |
Other Assets | 262K | 1.1M | 27K | 211K | (0.3) | (0.28) | |
Cash And Short Term Investments | 13.7M | 30.3M | 21.1M | 23.8M | 13.3M | 11.7M | |
Retained Earnings Total Equity | (131.3M) | (144.0M) | (162.1M) | (179.5M) | (161.5M) | (153.5M) | |
Common Stock Shares Outstanding | 19.9M | 23.7M | 26.0M | 26.3M | 26.6M | 27.9M | |
Liabilities And Stockholders Equity | 14.1M | 31.4M | 22.4M | 26.9M | 26.9M | 16.1M | |
Non Current Liabilities Total | 1.6M | 1.6M | 5.0M | 24.9M | 30.9M | 32.5M | |
Other Current Assets | 234K | 1.1M | 253K | 833K | 2.6M | 2.7M | |
Other Stockholder Equity | 48.3M | 49.2M | 53.2M | 56.8M | 62.1M | 38.1M | |
Total Liab | 2.3M | 2.3M | 6.6M | 29.5M | 38.5M | 40.4M | |
Total Current Assets | 13.9M | 31.4M | 22.4M | 26.7M | 26.9M | 28.2M | |
Capital Surpluse | 44.9M | 48.3M | 49.2M | 53.2M | 61.2M | 49.4M | |
Net Invested Capital | 11.9M | 29.1M | 20.8M | 22.3M | 19.3M | 17.3M | |
Net Working Capital | 11.6M | 29.1M | 20.7M | 22.1M | 19.3M | 17.2M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Fennec Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fennec Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fennec Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fennec Pharmaceuticals Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share 1.814 | Quarterly Revenue Growth 0.07 | Return On Assets 0.027 | Return On Equity (10.06) |
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.